EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

A Healthy Vaginal Microbiota Remains Stable during Oral Probiotic Supplementation: A Randomised Controlled Trial

Anna Lyra, Reeta Ala-Jaakkola, Nicolas Yeung, Neeta Datta, Kara Evans, Ashley Hibberd iD, Markus J Lehtinen, Sofia D Forssten, Alvin Ibarra, Tommi Pesonen, Jouni Junnila iD, Arthur C Ouwehand iD und 4 weitere

Microorganisms · 16.02.2023 · 11 (2) · 499

DOI: 10.3390/microorganisms11020499 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Microorganisms, online erschienen am 16.02.2023. Verfasst von Anna Lyra und 15 weiteren Autor:innen. Beteiligte Einrichtung: IFF Health & Biosciences, 02460 Kantvik, Finland. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danisco Sweeteners Oy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The primary objective of this randomised, placebo-controlled, triple-blind study was to assess whether orally consumed Lactobacillus acidophilus La-14 (La-14) and Lacticaseibacillus rhamnosus HN001 (HN001) colonise a healthy human vagina. Furthermore, potential effects on vaginal microbiota and immune markers were explored. Fifty women devoid of vaginal complaints (Nugent score 0–3 and vaginal pH ≤ 4.5) were randomised into a 2-week intervention with either La-14 and HN001 as the verum product or a comparable placebo. Vaginal swab samples were collected at baseline, after one and two weeks of intervention, and after a one-week follow-up, for assessing colonisation of the supplemented lactobacilli, vaginal microbiota, and six specific immune markers. Colonisation of L. acidophilus and L. rhamnosus was not observed above the assay detection limit (5.29 and 5.11 log 10 genomes/swab for L. acidophilus and L. rhamnosus, respectively). Vaginal microbiotas remained stable and predominated by lactobacilli throughout the intervention, and vaginal pH remained optimal (at least 90% of participants in both groups had pH 4.0 or 4.5 throughout the study). Immune markers elafin and human β-defensin 3 (HBD-3) were significantly decreased in the verum group (p = 0.022 and p = 0.028, respectively) but did not correlate with any microbiota changes. Adverse events raised no safety concerns, and no undesired changes in the vaginal microbiota or immune markers were detected.

Schlagwörter

Stichwörter der Autor:innen

Lacticaseibacillus rhamnosusLactobacillus acidophilusimmune markerslactobacillimicrobiotaprobioticsvaginal colonisation

Autor:innen und Institutionen

  • IFF Health & Biosciences, 02460 Kantvik, Finland.
  • IFF Health & Biosciences, Madison, WI 53716, USA.
  • Oy 4Pharma Ltd., 20520 Turku, Finland.
  • EstiMates Oy, 20520 Turku, Finland.
  • CPS Research, Glasgow G20 7BE, UK.

ORCID-Profile: Ashley Hibberd, Jouni Junnila, Arthur C Ouwehand

Förderung

  • Danisco Sweeteners Oy

Zitieren

APA

Lyra, A., Ala-Jaakkola, R., Yeung, N., Datta, N., Evans, K., Hibberd, A., Lehtinen, M. J., Forssten, S. D., Ibarra, A., Pesonen, T., Junnila, J., Ouwehand, A. C., Baranowski, K., Maukonen, J., Crawford, G., & Lehtoranta, L. (2023). A Healthy Vaginal Microbiota Remains Stable during Oral Probiotic Supplementation: A Randomised Controlled Trial. Microorganisms, 11(2), 499. https://doi.org/10.3390/microorganisms11020499

Vancouver

Lyra A, Ala-Jaakkola R, Yeung N, Datta N, Evans K, Hibberd A, et al. A Healthy Vaginal Microbiota Remains Stable during Oral Probiotic Supplementation: A Randomised Controlled Trial. Microorganisms. 2023;11(2):499. doi:10.3390/microorganisms11020499

BibTeX
@article{Lyra2023,
  author = {Lyra, Anna and Ala-Jaakkola, Reeta and Yeung, Nicolas and Datta, Neeta and Evans, Kara and Hibberd, Ashley and Lehtinen, Markus J and Forssten, Sofia D and Ibarra, Alvin and Pesonen, Tommi and Junnila, Jouni and Ouwehand, Arthur C and Baranowski, Keith and Maukonen, Johanna and Crawford, Gordon and Lehtoranta, Liisa},
  title = {A Healthy Vaginal Microbiota Remains Stable during Oral Probiotic Supplementation: A Randomised Controlled Trial},
  journal = {Microorganisms},
  year = {2023},
  volume = {11},
  number = {2},
  pages = {499},
  doi = {10.3390/microorganisms11020499}
}
Kostenlos starten →